Parkinson's Disease (PD) is a common neurodegenerative disease which manifests with
motor features, such as bradykinesia, resting tremor, rigidity, and postural instability. Using …

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by
progressive loss of dopamine neurons and aberrant deposits of alpha‐synuclein (α‐syn) in …

Abstract α-Synuclein (α-syn) accumulates as insoluble amyloid but also forms soluble α-syn
oligomers (αSOs), thought to be even more cytotoxic than fibrils. To detect and block the …

Abstract Parkinson's disease (PD), being the second largest neurodegenerative disease,
poses challenges in early detection, resulting in a lack of timely treatment options to …

Introduction: Abnormal spreading of alpha-synuclein (αS), a hallmark of Parkinson's
disease, is known to promote peripheral inflammation, which occurs in part via functional …

Neurodegenerative diseases are characterized by progressive dysfunction and loss of
specific sets of neurons. While extensive research has focused on elucidating the genetic …

Poststroke cognitive impairment is a major secondary effect of ischemic stroke in many
patients; however, few options are available for the early diagnosis and treatment of this …

Over the last two decades there have been meaningful developments on biomarkers of
neurodegenerative diseases, extensively (but not solely) focusing on their proteinopathic …

Aging is interrelated with changes in red blood cell parameters and functionality. In this
article, we focus on red blood cells (RBCs) and provide a review of the known changes …

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by
progressive loss of dopamine neurons and aberrant deposits of alpha-synuclein (a-syn) in …